Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
sicklecellanemianews
9h
Pfizer withdraws Oxbryta from global markets, cites safety concerns
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Iran launches missile attack
'Good Times' star dies
Helene wreaks havoc
How to watch VP debate
Files for bankruptcy
Pledges support for Ukraine
Kentucky sheriff steps down
Tony-winning star dies
FL homeless law kicks in
Broadway star dies at 70
'Pled guilty to journalism'
Settlement checks delayed
Wausau drop box replaced
Asylum restrictions extended
To lay off 2,900 employees
Top Adams aide resigns
Arkansas sues YouTube
CA bans legacy admissions
Explosive devices found
Jimmy Carter turns 100
TX fraud probe shut down
GA abortion ban blocked
US sanctions settler group
194K Jeep SUVs recalled
Georgia election rules trial
Breast cancer deaths fall
Tulsa Race Massacre probe
Feedback